To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Additional recommended knowledge
EIPT is short for N-ethyl-N-isopropyl-tryptamine. The full chemical name of this structure is N-ethyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]propan-2-amine. EIPT is a tryptamine, which all belong to a larger family of compounds known as indolethylamines. EIPT is closely related to the compounds DET and DIPT.
In his book TiHKAL, Alexander Shulgin lists a dosage for EIPT as being 24-40 mg taken orally.
Very little is known about the psychopharmacological properties of EIPT, but reports suggest it produces psychedelic effects that can last 4-6 hours. According to Shulgin, this compound tends to produce nausea, dysphoria, and other unpleasant side-effects. It also lacks the hallucinatory and visual properties usually associated with psychedelic drugs.
There have been no reported deaths or hospitalizations from EIPT, but its safety profile is unknown.
EIPT is unscheduled and uncontrolled in the United States, but possession and sales of EIPT could be prosecuted under the Federal Analog Act because of its structural similarities to DET.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Ethylisopropyltryptamine". A list of authors is available in Wikipedia.|